🎉 M&A multiples are live!
Check it out!

Fortress Biotech Valuation Multiples

Discover revenue and EBITDA valuation multiples for Fortress Biotech and similar public comparables like Benevolent AI, Pharming, and Julphar.

Fortress Biotech Overview

About Fortress Biotech

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.


Founded

2006

HQ

United States of America
Employees

101

Financials

LTM Revenue $62.1M

LTM EBITDA n/a

EV

$65.1M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Fortress Biotech Financials

Fortress Biotech has a last 12-month revenue of $62.1M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Fortress Biotech achieved revenue of $57.7M and an EBITDA of -$104M.

Fortress Biotech expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Fortress Biotech valuation multiples based on analyst estimates

Fortress Biotech P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $84.5M $57.7M XXX XXX XXX
Gross Profit $45.0M $57.9M XXX XXX XXX
Gross Margin 53% 100% XXX XXX XXX
EBITDA -$134M -$104M XXX XXX XXX
EBITDA Margin -158% -181% XXX XXX XXX
Net Profit -$86.6M -$60.6M XXX XXX XXX
Net Margin -102% -105% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Fortress Biotech Stock Performance

As of April 15, 2025, Fortress Biotech's stock price is $2.

Fortress Biotech has current market cap of $46.4M, and EV of $65.1M.

See Fortress Biotech trading valuation data

Fortress Biotech Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$65.1M $46.4M XXX XXX XXX XXX $-2.41

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Fortress Biotech Valuation Multiples

As of April 15, 2025, Fortress Biotech has market cap of $46.4M and EV of $65.1M.

Fortress Biotech's trades at 1.0x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Fortress Biotech's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Fortress Biotech and 10K+ public comps

Fortress Biotech Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $65.1M XXX XXX XXX
EV/Revenue 1.1x XXX XXX XXX
EV/EBITDA -0.6x XXX XXX XXX
P/E -1.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -0.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Fortress Biotech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Fortress Biotech Valuation Multiples

Fortress Biotech's NTM/LTM revenue growth is 42%

Fortress Biotech's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $1.5M for the same period.

Over next 12 months, Fortress Biotech's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Fortress Biotech's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Fortress Biotech and other 10K+ public comps

Fortress Biotech Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -32% XXX XXX XXX XXX
EBITDA Margin -181% XXX XXX XXX XXX
EBITDA Growth -22% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -139% XXX XXX XXX XXX
Revenue per Employee $0.6M XXX XXX XXX XXX
Opex per Employee $1.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 99% XXX XXX XXX XXX
Opex to Revenue 257% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Fortress Biotech Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Fortress Biotech M&A and Investment Activity

Fortress Biotech acquired  XXX companies to date.

Last acquisition by Fortress Biotech was  XXXXXXXX, XXXXX XXXXX XXXXXX . Fortress Biotech acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Fortress Biotech

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Fortress Biotech

When was Fortress Biotech founded? Fortress Biotech was founded in 2006.
Where is Fortress Biotech headquartered? Fortress Biotech is headquartered in United States of America.
How many employees does Fortress Biotech have? As of today, Fortress Biotech has 101 employees.
Who is the CEO of Fortress Biotech? Fortress Biotech's CEO is Dr. Lindsay A. Rosenwald, M.D..
Is Fortress Biotech publicy listed? Yes, Fortress Biotech is a public company listed on NAS.
What is the stock symbol of Fortress Biotech? Fortress Biotech trades under FBIO ticker.
When did Fortress Biotech go public? Fortress Biotech went public in 2011.
Who are competitors of Fortress Biotech? Similar companies to Fortress Biotech include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Fortress Biotech? Fortress Biotech's current market cap is $46.4M
What is the current revenue of Fortress Biotech? Fortress Biotech's last 12-month revenue is $62.1M.
What is the current EV/Revenue multiple of Fortress Biotech? Current revenue multiple of Fortress Biotech is 1.0x.
What is the current revenue growth of Fortress Biotech? Fortress Biotech revenue growth between 2023 and 2024 was -32%.
Is Fortress Biotech profitable? Yes, Fortress Biotech is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.